You're reading the free version. Trader adds the live tape and alerts.
Start tracking
UNCY Award Disclosure
Jermasek Douglas · SEC Form 4 · Filed Jun 15, 2026
Award
Calculated transaction value
$0
Jermasek Douglas EVP, Corporate Strategy
UNCY
Transaction date
May 14, 2026
Public filing date
Jun 15, 2026
Filing lag
Filed 32 days later
UNCY daily price context
Close on/before transaction
$8.56
May 14, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Units on Common Stock
- Quantity / price
- 169,500 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4/A
- Filing identifier
- 0001213900-26-068915
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Unicycive Therapeutics, Inc. UNCY Current | Award | May 14, 2026 | $0 |